Temsirolimus

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1490 publications

WIN-MTB-2024017 - WIN International Molecular Tumor Board: A 48-year-old female with multiple primary cancers.

WIN-MTB-2024017 - WIN International Molecular Tumor Board: A 48-year-old female with multiple primary cancers.

Journal: Oncotarget
Published: July 21, 2026

Deciphering the Leading-Edge Spatiotemporal Microenvironment of Hepatocellular Carcinoma for Targeted Drug Discovery Using SpaPred.

Deciphering the Leading-Edge Spatiotemporal Microenvironment of Hepatocellular Carcinoma for Targeted Drug Discovery Using SpaPred.

Journal: International journal of molecular sciences
Published: July 04, 2026

Simvastatin enhances the antitumor activity of temsirolimus through AMPK-associated metabolic modulation in clear-cell renal cell carcinoma.

Simvastatin enhances the antitumor activity of temsirolimus through AMPK-associated metabolic modulation in clear-cell renal cell carcinoma.

Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: June 05, 2026

Temsirolimus in Patients With Solid Tumors With PIK3CA Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

Temsirolimus in Patients With Solid Tumors With PIK3CA Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

Journal: JCO precision oncology
Published: April 22, 2026

Expression of Concern: Juengel et al. Mechanisms Behind Temsirolimus Resistance Causing Reactivated Growth and Invasive Behavior of Bladder Cancer Cells In Vitro. Cancers 2019, 11, 777.

Expression of Concern: Juengel et al. Mechanisms Behind Temsirolimus Resistance Causing Reactivated Growth and Invasive Behavior of Bladder Cancer Cells In Vitro. Cancers 2019, 11, 777.

Journal: Cancers
Published: March 18, 2026

USP14 inhibitor IU1 alleviates amyloid-β mediated toxicity in Alzheimer's disease cell and worm models.

USP14 inhibitor IU1 alleviates amyloid-β mediated toxicity in Alzheimer's disease cell and worm models.

Journal: Journal of Alzheimer's disease : JAD
Published: March 13, 2026

Enzymatic C42 Diversification of Rapamycin Identifies a Potent Butyryl-Modified Anticancer Derivative.

Enzymatic C42 Diversification of Rapamycin Identifies a Potent Butyryl-Modified Anticancer Derivative.

Journal: Organic letters
Published: February 24, 2026

Survival and Homeostasis of Alveolar Macrophages in Vivo Depend on mTOR Signaling.

Survival and Homeostasis of Alveolar Macrophages in Vivo Depend on mTOR Signaling.

Journal: American journal of respiratory cell and molecular biology
Published: February 04, 2026

Phosphorylated mTOR immunohistochemistry-guided use of temsirolimus in recurrent IDH-wildtype glioblastoma: a real-world retrospective series.

Phosphorylated mTOR immunohistochemistry-guided use of temsirolimus in recurrent IDH-wildtype glioblastoma: a real-world retrospective series.

Journal: Journal of cancer research and clinical oncology
Published: February 02, 2026

3D co-culture model of tumor spheroid and endothelial cells unveils ccRCC aberrant vasculature and distinct sensitivity to targeted treatments.

3D co-culture model of tumor spheroid and endothelial cells unveils ccRCC aberrant vasculature and distinct sensitivity to targeted treatments.

Journal: Angiogenesis
Published: January 09, 2026

Drug repurposing as a promising therapeutic strategy against renal cell carcinoma.

Drug repurposing as a promising therapeutic strategy against renal cell carcinoma.

Journal: Cancer chemotherapy and pharmacology
Published: January 01, 2026

Computer prediction and genetic analysis identifies retinoic acid modulation as a driver of conserved longevity pathways in genetically diverse Caenorhabditis nematodes.

Computer prediction and genetic analysis identifies retinoic acid modulation as a driver of conserved longevity pathways in genetically diverse Caenorhabditis nematodes.

Journal: eLife
Published: December 23, 2025
Showing 1-12 of 1,490

Last Updated: 09/26/2026